by Plus Therapeutics | May 2, 2024 | LM
❗NEW CLINICAL TRIAL INVESTIGATION SITE❗ We are pleased to announce the addition of North Shore University Hospital in New York to our ReSPECT-LM Clinical Trial with Principal Investigator Michael Schulder, M.D.. This site is NOW ENROLLING patients. Michael Schulder,...
by Plus Therapeutics | May 1, 2024 | Uncategorized
Brain tumor research is at the heart of what we do. Our team focuses every day on how to fight for a cure, and we are passionate about the Brain Cancer community. 🧠🎗️ We have some great education events and news this month that we look forward to sharing with you all,...
by Plus Therapeutics | Apr 29, 2024 | PBC
Following our EXCITING NEWS about our $3 Million award recommendation from the United States Department of Defense, we wanted to reshare our cancer guides for Pediatric High-Grade Glioma (https://www.respect-trials.com/patient-guide-hgg/) and Ependymoma...
by Plus Therapeutics | Apr 26, 2024 | Uncategorized
Come join us at the American Association of Neurological Surgeons (AANS) Annual Meeting in Chicago, IL next week! Visit our booth to learn about our #clinicaltrials for #patients with recurrent #glioblastoma, leptomeningeal #metastases, & pediatric #braincancer...
by Plus Therapeutics | Apr 25, 2024 | Uncategorized
“Plus Therapeutics’ commitment to revolutionizing cancer treatment extends beyond this latest award. With $23 million in active awards support, the company is at the forefront of targeted radiotherapeutic research. Moreover, ongoing trials, including...
Recent Comments